> A New Jersey court ruled that Actavis ($ACT) generics violate 7 Depomed patents of its Gralise (gabapentin) tablets for the management of postherpetic neuralgia, which are based on its proprietary Acuform drug delivery technology. Release | Story
> Drug delivery specialist EastGate Acquisitions said that it is trying to acquire the licensing rights to develop and manufacture an intraoral insulin formulation. Release
> The FDA issued a Class I recall of Enhancement Medical's Expression intranasal splint, saying it is dangerous when injected subcutaneously, especially when used off-label as a dermal filler. Story
> The U.S. National Institutes of Health is inviting scientists to apply for funding of research into platform delivery technologies for nucleic acid therapeutics. Announcement